Real-time enrollment status for this metastatic hepatocellular carcinoma clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 6:42 AM UTC
| NCT Number | NCT06915753 |
| Recruiting Status | Recruiting |
| Condition | Metastatic Hepatocellular Carcinoma |
| Phase | Clinical Trial |
| Target Enrollment | 100 participants |
| Active Locations | 9 sites in the US |
| Sponsor | Tyra Biosciences, Inc |
| Last Updated on CT.gov | November 20, 2025 (Nov 20, 2025) |
As of July 13, 2026: Clinical trial NCT06915753 is currently recruiting participants. This clinical trial study for metastatic hepatocellular carcinoma is actively seeking new participants at 9 locations across the United States. The study is sponsored by Tyra Biosciences, Inc. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06915753 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 9 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06915753 was last updated Nov 20, 2025 (November 20, 2025). HelloStudys verifies this status automatically.